Human Fertilisation and Embryology Authority
E28060
The Human Fertilisation and Embryology Authority is the UK’s independent regulator overseeing fertility treatment and embryo research to ensure safety, ethical standards, and compliance with the law.
All labels observed (3)
| Label | Occurrences |
|---|---|
| Human Fertilisation and Embryology Authority canonical | 5 |
| HFEA | 1 |
| Interim Licensing Authority for Human In Vitro Fertilisation and Embryology | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T219130 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Human Fertilisation and Embryology Authority Context triple: [Department of Health and Social Care, oversees, Human Fertilisation and Embryology Authority]
-
A.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
B.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
C.
Babraham Research Campus
Babraham Research Campus is a major life sciences research and innovation hub near Cambridge, England, focused on bioscience, biotechnology, and academic–industry collaboration.
-
D.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
E.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Human Fertilisation and Embryology Authority Target entity description: The Human Fertilisation and Embryology Authority is the UK’s independent regulator overseeing fertility treatment and embryo research to ensure safety, ethical standards, and compliance with the law.
-
A.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
B.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
C.
Babraham Research Campus
Babraham Research Campus is a major life sciences research and innovation hub near Cambridge, England, focused on bioscience, biotechnology, and academic–industry collaboration.
-
D.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
E.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
- F. None of above. chosen
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
non-departmental public body
ⓘ
public body of the United Kingdom ⓘ regulatory authority ⓘ |
| country | United Kingdom ⓘ |
| dataHeld |
data on success rates of fertility clinics
ⓘ
national fertility treatment statistics ⓘ |
| established | 1991 ⓘ |
| foundedBy |
British Parliament
ⓘ
surface form:
Parliament of the United Kingdom
|
| fundingSource |
UK government
ⓘ
clinic licence fees ⓘ |
| governance | board of authority members ⓘ |
| headquartersCountry | United Kingdom ⓘ |
| headquartersLocation |
London, England
ⓘ
surface form:
London
|
| jurisdiction | United Kingdom ⓘ |
| legalBasis |
Human Fertilisation and Embryology Act 1990
ⓘ
Human Fertilisation and Embryology Act 2008 ⓘ |
| parentOrganization | Department of Health and Social Care ⓘ |
| precededBy |
Human Fertilisation and Embryology Authority
self-linksurface differs
ⓘ
surface form:
Interim Licensing Authority for Human In Vitro Fertilisation and Embryology
|
| purpose |
to ensure compliance with UK fertility and embryo law
ⓘ
to ensure patient safety in fertility treatment ⓘ to license and monitor fertility treatment and embryo research ⓘ to regulate fertility clinics in the United Kingdom ⓘ to uphold ethical standards in assisted reproduction ⓘ |
| regulates |
assisted reproductive technology
ⓘ
donor insemination ⓘ embryo research ⓘ fertility treatment ⓘ in vitro fertilisation ⓘ storage of gametes and embryos ⓘ |
| regulatoryScope |
donation of eggs, sperm and embryos
ⓘ
use and storage of human eggs and sperm ⓘ use of human embryos outside the body ⓘ |
| responsibility |
advising the UK government on assisted reproduction
ⓘ
approving certain embryo research projects ⓘ inspecting licensed fertility clinics ⓘ issuing licences to fertility clinics ⓘ maintaining a register of donors and donor-conceived people ⓘ maintaining a register of fertility treatments ⓘ monitoring clinic performance and outcomes ⓘ providing information to patients about fertility treatment ⓘ setting standards for fertility treatment ⓘ |
| sector | healthcare regulation ⓘ |
| shortName |
Human Fertilisation and Embryology Authority
self-linksurface differs
ⓘ
surface form:
HFEA
|
| website | https://www.hfea.gov.uk/ ⓘ |
| worksWith |
National Health Service
ⓘ
patient advocacy groups ⓘ professional fertility societies ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Human Fertilisation and Embryology Authority Description of subject: The Human Fertilisation and Embryology Authority is the UK’s independent regulator overseeing fertility treatment and embryo research to ensure safety, ethical standards, and compliance with the law.
Referenced by (7)
Full triples — surface form annotated when it differs from this entity's canonical label.
Human Fertilisation and Embryology Authority
→
shortName
→
Human Fertilisation and Embryology Authority
self-linksurface differs
ⓘ
this entity surface form:
HFEA
Human Fertilisation and Embryology Authority
→
precededBy
→
Human Fertilisation and Embryology Authority
self-linksurface differs
ⓘ
this entity surface form:
Interim Licensing Authority for Human In Vitro Fertilisation and Embryology
Human Fertilisation and Embryology Act 2008
→
establishesRegulatoryFrameworkFor
→
Human Fertilisation and Embryology Authority
ⓘ
Human Fertilisation and Embryology Act 2008
→
continuesRegulatoryRoleOf
→
Human Fertilisation and Embryology Authority
ⓘ
Human Fertilisation and Embryology Act 1990
→
establishes
→
Human Fertilisation and Embryology Authority
ⓘ
Human Fertilisation and Embryology Act 1990
→
createsBody
→
Human Fertilisation and Embryology Authority
ⓘ